Health Policy & Reimbursement Director
Amgen
Summary
Let’s do this. Let’s change the world. In this vital role you will lead development and implementation of federal payment policy strategies for federal (US) payer issues across one or more therapeutic areas and the company’s biosimilar portfolio. He/she will work cross-functionally to help identify and resolve federal payment policy barriers to entry for pipeline products/ therapies, provide federal payment policy-related advice for inline products, and manage assigned aspects of Federal (US) payer policy agency engagement. He/she will also serve as the lead analyst for Federal economic policy releases addressing drug payment policy and provide policy support for 340B. Additionally, he/she will provide insights into strategic engagement with key agencies including HHS and CMS.
Job description
What you will do
Let’s do this. Let’s change the world. In this vital role you will lead development and implementation of federal payment policy strategies for federal (US) payer issues across one or more therapeutic areas and the company’s biosimilar portfolio. He/she will work cross-functionally to help identify and resolve federal payment policy barriers to entry for pipeline products/ therapies, provide federal payment policy-related advice for inline products, and manage assigned aspects of Federal (US) payer policy agency engagement. He/she will also serve as the lead analyst for Federal economic policy releases addressing drug payment policy and provide policy support for 340B. Additionally, he/she will provide insights into strategic engagement with key agencies including HHS and CMS.
He/she will review and analyze policy proposals (both in regulation and legislative text) in assigned areas, communicate key proposals to key internal audiences, and lead engagement with Federal payer agencies in support of assigned payment policy objectives. This position requires strong collaboration across functions including colleagues in Government Affairs, Commercial, Medical, Development, Regulatory, Law, and other functions. Additionally, the individual will need to conduct relevant policy research and integrate clinical, market, and payer information to engage on federal payment policy objectives. The Health Policy Director will regularly update via written and oral communications to key partners on various reimbursement and US health policy topics.
The position is based in Washington, DC.
What we expect of you
We are all different, yet we all use our unique contributions to serve patients. The professional we seek is a leader with these qualifications.
Basic Qualifications:
Doctorate degree and 4 years of relevant experience OR Master’s degree and 7 years of relevant experience OR Bachelor’s degree and 9 years of relevant experience
Preferred Qualifications:
- Deep understanding of Federal (US) payer environment including areas of (1) healthcare product and service coverage, coding, and reimbursement, (2) health policy, and (3) Federal (US) Executive and Legislative Branch healthcare policy-setting authorities, processes, and responsible parties
- Broad and deep experience in federal health policy issues – specifically Medicare, Medicaid, and national health programs
- Deep understanding of US biosimilars marketplace and its history/evolution
- Experience working for or with key Federal agencies such as HHS and CMS coupled with strategic insights in how to successfully engage with key staff in the agencies
- Experience reviewing clinical literature, including disease state information and target product profiles to understand implications of payer actions and develop submissions for Federal programs like Medicare
- Demonstrated communication skills including both interpersonal skills to foster collaboration and oral/written presentation skills/comfort level speaking to senior executives
- Experience with reviewing Federal cost estimates for health policy proposals
- Product commercialization experience desirable (direct or consultant)
- Experience in Amgen therapeutic areas preferred (health policy or product)
- Experience in multi-stakeholder groups (trade associations or disease-specific groups)
Requirements
- Doctorate degree and 4 years of relevant experience OR Master’s degree and 7 years of relevant experience OR Bachelor’s degree and 9 years of relevant experience
- Deep understanding of Federal (US) payer environment including healthcare product and service coverage, coding, and reimbursement
- Deep understanding of health policy and Federal (US) Executive and Legislative Branch healthcare policy-setting authorities, processes, and responsible parties
- Broad and deep experience in federal health policy issues – specifically Medicare, Medicaid, and national health programs
- Deep understanding of US biosimilars marketplace and its history/evolution
- Experience working for or with key Federal agencies such as HHS and CMS
- Experience reviewing clinical literature, including disease state information and target product profiles
- Demonstrated communication skills including interpersonal skills and oral/written presentation skills
- Experience with reviewing Federal cost estimates for health policy proposals
- Product commercialization experience desirable
- Experience in Amgen therapeutic areas preferred
- Experience in multi-stakeholder groups (trade associations or disease-specific groups)
Benefits
- Retirement and Savings Plan
- Medical Insurance
- Dental Insurance
- Vision Coverage
- Life Insurance
- Disability Insurance
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-Based Long-Term Incentives
- Paid Time Off
- Flexible Work Models
- Career Development Opportunities
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.